Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
7.90
-0.82 (-9.40%)
At close: Oct 30, 2026, 4:00 PM EDT
8.14
+0.24 (3.04%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Moleculin Biotech Employees
Moleculin Biotech had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Moleculin Biotech the 38,911th largest employer in the world and 5,632nd in the United States.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,913,235
Market Cap
7.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - | 17 | 0 |
| Dec 31, 2024 | 17 | -1 | -5.56% | 17 | 0 |
| Dec 31, 2023 | 18 | -1 | -5.26% | 18 | 0 |
| Dec 31, 2022 | 19 | 2 | 11.76% | 15 | 4 |
| Dec 31, 2021 | 17 | 2 | 13.33% | 13 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Palatin Technologies | 25 |
| Lisata Therapeutics | 21 |
| Theriva Biologics | 16 |
| Soligenix | 14 |
| Actuate Therapeutics | 12 |
| Ensysce Biosciences | 10 |
| MetaVia | 8 |
MBRX News
- 1 day ago - Moleculin Biotech completes dosing in Part A of MIRACLE trial - TheFly
- 1 day ago - Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027 - GlobeNewsWire
- 11 days ago - Moleculin Releases Next CEO Corner Segment Highlighting Recent Progress in Annamycin MIRACLE Trial - GlobeNewsWire
- 12 days ago - Moleculin Biotech trading halted, news pending - TheFly
- 15 days ago - Moleculin Biotech announces 1-for-20 reverse stock split - TheFly
- 15 days ago - Moleculin Announces Reverse Stock Split - GlobeNewsWire
- 24 days ago - Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit - GlobeNewsWire
- 4 weeks ago - Moleculin Biotech completes enrollment in Part A of Phase 2/3 R/R MIRACLE trial - TheFly